A 7.5 mg dose at this concentration means injecting 1.5 mL, which is at the upper limit of what most people find comfortable for a subcutaneous injection
Although both pharmacological approaches target GLP-1, important differences exist concerning the mode of administration (subcutaneous injection versus oral ingestion), the efficacy (better with GLP-1 agonists), the effects on body weight and systolic blood pressure (diminution with agonists versus neutrality with gliptins), the tolerance profile (nausea and possibly vomiting with agonists) and the cost (higher with GLP-1 receptor agonists)
A dietitian can guide you on making healthier food choices and developing better eating habits, which are vital for long-term success
Occasionally, some patients notice increased hair growth in areas they did not expect, which should be discussed with your provider
To report a serious adverse event or obtain product information, contact 1-866-280-2852